Skip to main content

Home›Research›Compare›Angiotensin (1-7) vs Klotho

Peptide Comparison

Angiotensin (1-7) vs Klotho

Both are Longevity & Cellular peptides.

Angiotensin (1-7)

Ang-(1-7)

LongevityInvestigationalResearch Only

Half-life: ~9–10 sec (rat)

No providers listed yet

Full Angiotensin (1-7) profile →
vs

Klotho

alpha-Klotho

LongevityNot EvaluatedResearch Only

1 providers listed

Full Klotho profile →
Bottom line

Klotho carries stronger published evidence (Meta-analysis, 8 key studies) than Angiotensin (1-7) (RCT, 9); both are research compounds.

Quick Verdict

Angiotensin (1-7)

Half-life

~9–10 sec (rat)

Klotho

Half-life

—

Which One Should You Choose?
Your goalBetter option
Stronger clinical evidenceKlotho
Further along in FDA reviewAngiotensin (1-7)
More provider options (0 vs 1)Klotho

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Angiotensin (1-7)
Klotho
Mechanism Family
Longevity & Cellular
Longevity & Cellular
Half-life
~9–10 sec (rat)
—
FDA Status
investigational
not evaluated
Admin Routes
subcutaneous, intravenous
subcutaneous, intravenous
Availability
Research Only
Research Only
Providers
None listed
1 listed
Research Evidence

Angiotensin (1-7)

RCT · 9 key studies · most recent 2026

Klotho

Meta-analysis · 8 key studies · most recent 2026
Research Citations

About Angiotensin (1-7)

Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.

Research Areas
cardiovascular protectionanti-fibroticvasodilationinsulin sensitivitykidney protection

About Klotho

Acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. As a circulating hormone, inhibits insulin/IGF-1 signaling to extend lifespan, activates Nrf2 antioxidant pathways, and suppresses TGF-β fibrotic signaling.

Research Areas
neuroprotectioncardiovascular protectionanti-agingcognitive supportanti-fibrotic
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Angiotensin (1-7)

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Klotho

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Longevity & Cellular Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.